Literature DB >> 30410853

Control of CNS functions by RNA-binding proteins in neurological diseases.

Yijing Zhou1, Fengping Dong1, Yingwei Mao1.   

Abstract

PURPOSE OF REVIEW: This review summarizes recent studies on the molecular mechanisms of RNA binding proteins (RBPs) that control neurological functions and pathogenesis in various neurodevelopmental and neurodegenerative diseases, including autism spectrum disorders, schizophrenia, Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, and spinocerebellar ataxia. RECENT
FINDINGS: RBPs are critical players in gene expression that regulate every step of posttranscriptional modifications. Recent genome-wide approaches revealed that many proteins associate with RNA, but do not contain any known RNA binding motifs. Additionally, many causal and risk genes of neurodevelopmental and neurodegenerative diseases are RBPs. Development of high-throughput sequencing methods has mapped out the fingerprints of RBPs on transcripts and provides unprecedented potential to discover new mechanisms of neurological diseases. Insights into how RBPs modulate neural development are important for designing effective therapies for numerous neurodevelopmental and neurodegenerative diseases.
SUMMARY: RBPs have diverse mechanisms for modulating RNA processing and, thereby, controlling neurogenesis. Understanding the role of disease-associated RBPs in neurogenesis is vital for developing novel treatments for neurological diseases.

Entities:  

Keywords:  RNA binding proteins; neurodegeneration; neurodevelopmental disorder

Year:  2018        PMID: 30410853      PMCID: PMC6217844          DOI: 10.1007/s40495-018-0140-7

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  190 in total

1.  Metformin ameliorates core deficits in a mouse model of fragile X syndrome.

Authors:  Ilse Gantois; Arkady Khoutorsky; Jelena Popic; Argel Aguilar-Valles; Erika Freemantle; Ruifeng Cao; Vijendra Sharma; Tine Pooters; Anmol Nagpal; Agnieszka Skalecka; Vinh T Truong; Shane Wiebe; Isabelle A Groves; Seyed Mehdi Jafarnejad; Clément Chapat; Elizabeth A McCullagh; Karine Gamache; Karim Nader; Jean-Claude Lacaille; Christos G Gkogkas; Nahum Sonenberg
Journal:  Nat Med       Date:  2017-05-15       Impact factor: 53.440

2.  Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA.

Authors:  Christian B F Andersen; Lionel Ballut; Jesper S Johansen; Hala Chamieh; Klaus H Nielsen; Cristiano L P Oliveira; Jan Skov Pedersen; Bertrand Séraphin; Hervé Le Hir; Gregers Rom Andersen
Journal:  Science       Date:  2006-08-24       Impact factor: 47.728

3.  Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia.

Authors:  Carissa Nadia Kuswanto; Puay-San Woon; Xue Bin Zheng; Anqi Qiu; Yih-Yian Sitoh; Yiong Huak Chan; Jianjun Liu; Hywel Williams; Wei Yi Ong; Kang Sim
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-02-10       Impact factor: 3.568

4.  Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.

Authors:  Melissa Ingram; Emily A L Wozniak; Christine Henzler; Lisa Duvick; Rendong Yang; Paul Bergmann; Robert Carson; Brennon O'Callaghan; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2016-03-03       Impact factor: 17.173

5.  Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.

Authors:  Kristin K Nicodemus; April Hargreaves; Derek Morris; Richard Anney; Michael Gill; Aiden Corvin; Gary Donohoe
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

6.  Deregulation of EIF4E: a novel mechanism for autism.

Authors:  M Neves-Pereira; B Müller; D Massie; J H G Williams; P C M O'Brien; A Hughes; S-B Shen; David St Clair; Z Miedzybrodzka
Journal:  J Med Genet       Date:  2009-06-25       Impact factor: 6.318

7.  The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons.

Authors:  Daiyu Honda; Shinsuke Ishigaki; Yohei Iguchi; Yusuke Fujioka; Tsuyoshi Udagawa; Akio Masuda; Kinji Ohno; Masahisa Katsuno; Gen Sobue
Journal:  FEBS Open Bio       Date:  2013-11-20       Impact factor: 2.693

8.  Modulation of hippocampal theta and hippocampal-prefrontal cortex function by a schizophrenia risk gene.

Authors:  Helena Cousijn; Elizabeth M Tunbridge; Michal Rolinski; George Wallis; Giles L Colclough; Mark W Woolrich; Anna C Nobre; Paul J Harrison
Journal:  Hum Brain Mapp       Date:  2015-03-10       Impact factor: 5.038

9.  Psychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine Structure.

Authors:  P J Michael Deans; Pooja Raval; Katherine J Sellers; Nicholas J F Gatford; Sanjay Halai; Rodrigo R R Duarte; Carole Shum; Katherine Warre-Cornish; Victoria E Kaplun; Graham Cocks; Matthew Hill; Nicholas J Bray; Jack Price; Deepak P Srivastava
Journal:  Biol Psychiatry       Date:  2016-09-15       Impact factor: 13.382

10.  ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.

Authors:  Tetsuro Murakami; Seema Qamar; Julie Qiaojin Lin; Gabriele S Kaminski Schierle; Eric Rees; Akinori Miyashita; Ana R Costa; Roger B Dodd; Fiona T S Chan; Claire H Michel; Deborah Kronenberg-Versteeg; Yi Li; Seung-Pil Yang; Yosuke Wakutani; William Meadows; Rodylyn Rose Ferry; Liang Dong; Gian Gaetano Tartaglia; Giorgio Favrin; Wen-Lang Lin; Dennis W Dickson; Mei Zhen; David Ron; Gerold Schmitt-Ulms; Paul E Fraser; Neil A Shneider; Christine Holt; Michele Vendruscolo; Clemens F Kaminski; Peter St George-Hyslop
Journal:  Neuron       Date:  2015-10-29       Impact factor: 17.173

View more
  2 in total

Review 1.  Autism spectrum disorder: insights into convergent mechanisms from transcriptomics.

Authors:  Mathieu Quesnel-Vallières; Robert J Weatheritt; Sabine P Cordes; Benjamin J Blencowe
Journal:  Nat Rev Genet       Date:  2019-01       Impact factor: 53.242

Review 2.  The Biomarker and Therapeutic Potential of Circular Rnas in Schizophrenia.

Authors:  Artem Nedoluzhko; Natalia Gruzdeva; Fedor Sharko; Sergey Rastorguev; Natalia Zakharova; Georgy Kostyuk; Vadim Ushakov
Journal:  Cells       Date:  2020-10-04       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.